Ben Gil Price

Director, Sarepta Therapeutics.

Companies

MetaVia Inc.Chief executive officer Nov 4, 2021 to Nov 4, 2021¹
MetaVia Inc.President Nov 4, 2021 to Nov 4, 2021¹
Opus Genetics, Inc.Board member Dec 3, 2018 to Jun 7, 2019²
Sarepta TherapeuticsBoard member Nov 8, 2007 to Mar 16, 2016³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMetaVia Inc., Chief executive officer
2
SEC EDGAROpus Genetics, Inc., Board member
3
SEC EDGARSarepta Therapeutics, Board member